Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY)

Market Cap	8.38B -5.7%
Revenue (ttm)	41.77B +4.4%
Net Income	842.24M +33.8%
EPS	0.23 +33.6%
Shares Out	n/a
PE Ratio	9.95
Forward PE	14.45
Dividend	0.24 (3.26%)
Ex-Dividend Date	Jul 16, 2026

Volume	n/a
Open	7.34
Previous Close	7.34
Day's Range	7.34 - 7.34
52-Week Range	7.07 - 8.32
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHPMY

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1994
• Employees: 49,608
• Stock Exchange: OTCMKTS
• Ticker Symbol: SHPMY

Financial Performance

In 2025, SHPMY's revenue was 283.58 billion, an increase of 3.03% compared to the previous year's 275.25 billion. Earnings were 5.72 billion, an increase of 25.74%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 20, 2026

Data Sources Report a data error